Indefinite Delivery Contract SPE2DX15D9167

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, with a ceiling value of $499,999,999 and a period of performance through November 2026. The contract allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide.

The task orders issued under this IDC, valued at approximately $1,772 to $13,087, demonstrate the diverse pharmaceutical portfolio DMS Pharmaceutical Group provides to the Department of Defense (DoD), covering product categories such as injections, tablets, creams, auto-injectors, and specialty medications. This contract is not associated with any set-aside designations, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal awards across multiple medical domains and fulfill the DoD's pharmaceutical supply requirements at various military healthcare sites located in Park Ridge, Illinois.